Propensity Score-Matched Analysis of Effects of Clinical Characteristics and Treatment on Gender Difference in Outcomes After Acute Myocardial Infarction

Gender differences in coronary heart disease

“…The study concluded that women admitted with AMI received fewer effective treatments, as defined by the study, and have a twofold higher 30-day mortality. When adjusting for both baseline characteristics and treatment (medical treatment, angiography and reperfusion), there was a similar in-hospital and 30-day mortality between genders, suggesting that a higher use of invasive procedures and reperfusion strategy could reduce the difference in mortality 13. A large multicentre registry from Poland also showed similar results.…”

A Meta-analysis of the Association of Estimated GFR, Albuminuria, Age, Race, and Sex With Acute Kidney Injury

“…Disparities in income and health insurance may partially explain AKI disparities by race, 13 but it is unlikely that a similar explanation applies to the disparities by sex. Men face greater risk of cardiovascular events, and treatment for such events tends to be more aggressive in men than women, 35 with greater use of angiography, a common proximate cause of AKI. Alternatively, prostate cancer is one of the most common cancers among men, with an estimated 15.3% of men expected to be diagnosed during their lifetime; 36 both prostate cancer and its treatment are associated with AKI.…”

Management of Indigenous patients presenting with non ST‐segment elevation acute coronary syndrome in South Australia: a retrospective cohort study

“…The Australian guidelines for the management of ACS recommend that patients at high risk of a secondary cardiac event (except those with severe comorbidities) undergo angiography. The procedure examines the cause of acute ischaemia and the extent of underlying coronary artery disease (CAD), consequently influencing patient management . In addition, the guidelines recommend medications that should be prescribed before discharge for high‐risk patients: aspirin, clopidogrel, angiotensin‐converting enzyme inhibitor or angiotensin receptor antagonist, β blocker and statin.…”

“…To account for potential confounders, a propensity score was calculated based on cardiovascular risk factors (hypertension, diabetes and smoking status): history of previous infarction; percutaneous or surgical revascularisation; peripheral artery disease; and troponin release. Logistic regression with Indigenous status as the dependent variable was used to create the propensity score.…”